Clinical Trial Update: DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for DB-3Q bmMSC-EVs in patients with perianal fistulizing Crohn's disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• DB-3Q bmMSC-EVs (bone marrow mesenchymal stem cell-derived extracellular vesicles)

Snippet

Sponsor: Direct Biologics, LLC | Conditions: Perianal Fistula Due to Crohn's Disease | Phase 2 | Status: RECRUITING